METABOLYS has a total of 28 patent applications. It decreased the IP activity by 100.0%. Its first patent ever was published in 2011. It filed its patents most often in EPO (European Patent Office), WIPO (World Intellectual Property Organization) and Australia. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and measurement are SUZHOU VIGONVITA LIFE SCIENCES CO LTD, UNIV OF PUERTO RICO and TEMPEST THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | EPO (European Patent Office) | 5 | |
#2 | WIPO (World Intellectual Property Organization) | 4 | |
#3 | Australia | 3 | |
#4 | Canada | 3 | |
#5 | China | 3 | |
#6 | France | 3 | |
#7 | Republic of Korea | 3 | |
#8 | Brazil | 2 | |
#9 | United States | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Measurement |
# | Technology | |
---|---|---|
#1 | Therapeutic chemical compounds | |
#2 | Medical preparations | |
#3 | Heterocyclic compounds | |
#4 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Baverel Gabriel | 27 |
#2 | Moinet Gerard | 17 |
#3 | Ferrier Bernard | 15 |
#4 | Nazaret Remi | 12 |
#5 | Moinet Gérard | 10 |
#6 | Nazaret Rémi | 3 |
#7 | Gabriel Baverel | 1 |
#8 | Gérard Moinet | 1 |
Publication | Filing date | Title |
---|---|---|
EP3278802A1 | New treatment for the non alcoholic steatohepatitis and fibrosis | |
FR2999427A1 | Composition and kit comprising piperazine derivatives and metformin, their use in the treatment of diabetes | |
AU2012273977A1 | Piperazine derivatives, methods for preparing same, and uses thereof in the treatment of insulin resistance | |
FR2976942A1 | PIPERAZINE DERIVATIVES, PROCESSES FOR THEIR PREPARATION AND USES THEREOF IN THE TREATMENT OF INSULIN RESISTANCE |